This topic contains a solution. Click here to go to the answer

Author Question: When promoting average cost pricing, regulators A) include what they consider to be a normal rate ... (Read 41 times)

Diane

  • Hero Member
  • *****
  • Posts: 576
When promoting average cost pricing, regulators
 
  A) include what they consider to be a normal rate of return on investment.
  B) encourage firms to produce at the output level where price equals marginal cost.
  C) fail to consider a return to investors, so regulated firms often have a hard time raising investment funds.
  D) inflate costs so much that price ends up as large as would prevail under unregulated monopoly.

Question 2

Because there are low barriers to entry in a monopolistically competitive market
 
  A) there are many firms in the industry.
  B) they produce a homogeneous product.
  C) the firms are price takers.
  D) there is no non-price competition.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

paavo

  • Sr. Member
  • ****
  • Posts: 301
Answer to Question 1

A

Answer to Question 2

A




Diane

  • Member
  • Posts: 576
Reply 2 on: Jun 29, 2018
Wow, this really help


bulacsom

  • Member
  • Posts: 329
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library